Found: 94
Select item for more details and to access through your institution.
Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature.
- Published in:
- 2006
- By:
- Publication type:
- journal article
15-year remission in refractory FLT3-mutated AML attained by sorafenib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4801, doi. 10.1007/s00277-024-06012-3
- By:
- Publication type:
- Article
Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all- trans retinoic acid.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 12, p. 2171, doi. 10.1007/s00432-015-1987-1
- By:
- Publication type:
- Article
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 6, p. 831, doi. 10.15252/emmm.201404396
- By:
- Publication type:
- Article
Absence of early platelet increment in healthy mice during decitabine treatment.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-26821-8
- By:
- Publication type:
- Article
Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 19, p. e152, doi. 10.1093/nar/gku775
- By:
- Publication type:
- Article
Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. e194, doi. 10.1111/bjh.16615
- By:
- Publication type:
- Article
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 583, doi. 10.1111/bjh.15563
- By:
- Publication type:
- Article
Phase I dose‐escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 6, p. 1018, doi. 10.1111/bjh.15204
- By:
- Publication type:
- Article
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial).
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 2, p. 235, doi. 10.1111/bjh.15546
- By:
- Publication type:
- Article
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 6, p. 830, doi. 10.1111/bjh.15461
- By:
- Publication type:
- Article
Elevated fetal haemoglobin is a predictor of better outcome in MDS/ AML patients receiving 5-aza-2′-deoxycytidine (Decitabine).
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 609, doi. 10.1111/bjh.14463
- By:
- Publication type:
- Article
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 3, p. 361, doi. 10.1111/bjh.13138
- By:
- Publication type:
- Article
A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 2, p. 214, doi. 10.1111/bjh.12518
- By:
- Publication type:
- Article
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 10, p. 689, doi. 10.1002/gcc.22760
- By:
- Publication type:
- Article
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 11, p. 547, doi. 10.1002/gcc.22667
- By:
- Publication type:
- Article
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML‐10 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 486, doi. 10.1002/ajh.27196
- By:
- Publication type:
- Article
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42417-w
- By:
- Publication type:
- Article
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01596-5
- By:
- Publication type:
- Article
Epigenetic Priming of AML Blasts for All-<i>trans</i> Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075258
- By:
- Publication type:
- Article
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2339, doi. 10.1007/s00277-021-04494-z
- By:
- Publication type:
- Article
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 1, p. 63, doi. 10.1007/s00277-020-04114-2
- By:
- Publication type:
- Article
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis.
- Published in:
- 2014
- By:
- Publication type:
- Letter
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year 'real-life' evaluation.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 3, p. 315, doi. 10.1007/s00277-012-1637-5
- By:
- Publication type:
- Article
Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 1, p. 27, doi. 10.1007/s00277-011-1332-y
- By:
- Publication type:
- Article
Advances in the treatment of acute myeloid leukemia: From chromosomal aberrations to biologically targeted therapy.
- Published in:
- Journal of Cellular Biochemistry, 2008, v. 104, n. 6, p. 2059, doi. 10.1002/jcb.21770
- By:
- Publication type:
- Article
Upstream and downstream targets of RUNX proteins.
- Published in:
- Journal of Cellular Biochemistry, 2003, v. 89, n. 1, p. 9, doi. 10.1002/jcb.10491
- By:
- Publication type:
- Article
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2913, doi. 10.1007/s00262-022-03202-8
- By:
- Publication type:
- Article
Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Epigenetic targets in hematopoietic malignancies.
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6489, doi. 10.1038/sj.onc.1206814
- By:
- Publication type:
- Article
Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR + Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4328, doi. 10.3390/cancers15174328
- By:
- Publication type:
- Article
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5926, doi. 10.3390/cancers14235926
- By:
- Publication type:
- Article
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3334, doi. 10.3390/cancers12113334
- By:
- Publication type:
- Article
Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report of four cases.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.
- Published in:
- ChemBioChem, 2020, v. 21, n. 16, p. 2329, doi. 10.1002/cbic.202000138
- By:
- Publication type:
- Article
Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01661-w
- By:
- Publication type:
- Article
Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 11, p. 2068, doi. 10.1002/ijc.35134
- By:
- Publication type:
- Article
Fast proliferating and slowly migrating non‐small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 6, p. 1029, doi. 10.1002/ijc.34783
- By:
- Publication type:
- Article